HighCape Capital

HighCape Capital is a United States-based growth equity firm founded in 2013 and focused on the life sciences sector. The firm invests in commercial-stage companies operating across biotechnology, medical devices, and connected health. It seeks to support businesses transitioning from early development into scalable, growth-oriented organizations. HighCape combines capital with operational expertise, leveraging a team of experienced industry executives. Its investment approach emphasizes active collaboration with management teams and long-term value creation in healthcare innovation.